These emerging treatments, Tirzepatide , represent a groundbreaking advancement in addressing obesity and conceivably other ailments . These drugs are categorized as GLP-1 receptor stimulators, indicating they function to replicate the body's GLP-1 peptide, stimulating metabolic release and lowering hunger . Although Tirzepatide each one functions